“Nahvalur is proud to partner with Susan G. Komen, an organization that has made a tremendous impact in the fight against breast cancer,” said Anthony Luo, Chief Marketing Officer at Nahvalur. “Through this collaboration, we want to create awareness, foster support, and contribute to a cause that touches so many lives around the world.”
Nahvalur is committed to making a tangible difference. 10% of all sales from the Nahvalur Schuylkill: Breast Cancer 2024 will be donated to Susan G. Komen, supporting their mission to fund groundbreaking research, provide patient care, and advocate for better treatment options. By purchasing this pen, you are not only investing in a beautiful writing instrument but also contributing to the fight against breast cancer.
Together, we can make a meaningful impact and help create a future where breast cancer is no longer a threat.
This pen is currently available for pre-order, starting today, October 8th. The official release date is set for October 15th.